Optimer Pharmaceuticals

Optimer Pharmaceuticals Inc (NASDAQ: OPTR) was a biopharmaceutical company, originally based in San Diego, CA and later its headquarters were moved to Jersey City, NJ 07302, United States of America. The company focused on developing specialty drugs to treat gastrointestinal infections and related diseases. In 2011, it received regulatory approval for the first antibacterial drug, Dificid, in 25 years approved to treat certain types of diarrhea (i.e., Clostridium difficile induced diarrhea) in adults. But sales of the drug Dificid failed to meet expectations and the drug faced strong competition from cheaper generic alternatives.

Optimer Pharmaceuticals

Optimer Pharmaceuticals Inc (NASDAQ: OPTR) was a biopharmaceutical company, originally based in San Diego, CA and later its headquarters were moved to Jersey City, NJ 07302, United States of America. The company focused on developing specialty drugs to treat gastrointestinal infections and related diseases. In 2011, it received regulatory approval for the first antibacterial drug, Dificid, in 25 years approved to treat certain types of diarrhea (i.e., Clostridium difficile induced diarrhea) in adults. But sales of the drug Dificid failed to meet expectations and the drug faced strong competition from cheaper generic alternatives.